Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | AXSM | ARWR | ||
| Company | Biomarin Pharmaceuticals | Axsome Thera | Arrowhead Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 55.54 | 253.04 | 74.53 | ||
| High | 56.26 | 257.93 | 75.45 | ||
| Low | 55.48 | 253.04 | 73.29 | ||
| Latest | 55.95 | 255.17 | 74.52 | ||
| Change | +0.41 | +1.40 | +0.11 | ||
| % Change | +0.74% | +0.55% | +0.15% | ||
| Volume | 1,079,760 | 441,549 | 1,182,185 | ||
| 20-Day Average Volume | 2,505,487 | 650,911 | 1,492,976 | ||
| Previous Close | 55.54 | 253.77 | 74.41 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.17 | 235.28 | 74.97 | ||
| 20-Day Raw Stochastic | 76.00% | 97.76% | 45.82% | ||
| 20-Day Relative Strength | 53.19 | 72.80 | 51.45 | ||
| Weighted Alpha | -0.40 | +163.55 | +234.70 | ||
| Today's Opinion | 24% Sell | 100% Buy | 72% Buy | ||
| Previous Opinion | 40% Sell | 100% Buy | 72% Buy | ||
| Last Month's Opinion | 88% Sell | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.18% since 06/05/26 | +10.63% since 06/05/26 | +1.64% since 06/05/26 | ||
| Low | 55.25 on 06/11/26 | 233.29 on 06/08/26 | 69.51 on 06/10/26 | ||
| High | 58.26 on 06/10/26 | 257.92 on 06/12/26 | 76.20 on 06/09/26 | ||
| 1-Month | |||||
| %Chg | +6.09% since 05/12/26 | +14.72% since 05/12/26 | -6.01% since 05/12/26 | ||
| Low | 49.26 on 05/18/26 | 217.15 on 06/03/26 | 69.30 on 06/02/26 | ||
| High | 58.26 on 06/10/26 | 257.92 on 06/12/26 | 82.26 on 05/14/26 | ||
| 3-Month | |||||
| %Chg | -5.03% since 03/12/26 | +66.76% since 03/12/26 | +35.05% since 03/12/26 | ||
| Low | 49.26 on 05/18/26 | 152.28 on 03/24/26 | 54.02 on 03/13/26 | ||
| High | 60.71 on 03/13/26 | 257.92 on 06/12/26 | 82.26 on 05/14/26 | ||
| 6-Month | |||||
| %Chg | +5.23% since 12/12/25 | +73.46% since 12/12/25 | +5.99% since 12/12/25 | ||
| Low | 49.26 on 05/18/26 | 145.07 on 12/16/25 | 54.02 on 03/13/26 | ||
| High | 66.28 on 02/24/26 | 257.92 on 06/12/26 | 82.26 on 05/14/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,734,994 | 13,059,002 | 10,481,169 | ||
| Shares Outstanding, K | 193,284 | 51,460 | 140,857 | ||
| Annual Sales | 3,221,250,000 | 638,500,000 | 829,450,000 | ||
| Annual Net Income | 348,900,000 | -183,170,000 | -1,630,000 | ||
| Last Quarter Sales | 766,210,000 | 191,200,000 | 73,740,000 | ||
| Last Quarter Net Income | 105,530,000 | -64,540,000 | -132,730,000 | ||
| 60-Month Beta | 0.25 | 0.61 | 1.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.76 on 05/04/26 | -1.26 on 05/04/26 | -0.93 on 05/07/26 | ||
| Earnings Date | 08/03/26 | 08/03/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 27.67 | 0.00 | 0.00 | ||